Home » Topics » Regulatory

Regulatory
RSS

Celgene studies chirally pure mexiletine for relief of neuropathic pain

Oct. 9, 1997

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Geref cleared for pediatric growth disorders in U.S.

Oct. 8, 1997

First approval for Infergen

Oct. 8, 1997

Knoll receives FDA approval for Vicoprofen

Oct. 7, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Oct. 7, 1997

Nasonex Nasal Spray cleared for marketing in U.S.

Oct. 6, 1997

FDA clears Serevent Diskus

Oct. 3, 1997

Preclinical pharmacokinetic/efficacy data on MiKasome presented at ICAAC

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...